Skip to content

LSD: all studies

Page 240 of 282: studies 2,391 to 2,400 of 2,815, newest first. Back to the LSD overview

Research

Hallucinogens and dissociative drugs

Oxford University Press eBooks August 1, 2016 15 citations

Abstract Chapter 15 of Addiction Medicine covers hallucinogens and dissociative drugs. Hallucinogens are a large and diverse group of substances, some of which occur in fungi and plants and some which are chemically synthesized. Psychostimulants described in this chapter include psilocybin, mescaline, ayahuasca, lysergic acid diethylamide (LSD), and NBOMes and tryptamines. Dissociative drugs...

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice.

Journal of Visualized Experiments July 9, 2016 Terrell Holloway, José L. Moreno, Javier González-Maeso

The heteromeric receptor complex between 5-HT2A and mGlu2 has been implicated in some of the behavioral phenotypes in mouse models of psychosis(1,2). Consequently, investigation of structural details of the interaction between 5-HT2A and mGlu2 affecting schizophrenia-related behaviors represents a powerful translational tool. As previously shown, the head-twitch response (HTR) in mice is...

The Unquiet Mind Cancer: The Metaethical Quandary of Therapies

Journal of Cancer Research and Therapeutics July 1, 2016 Rohit Manchanda

Authors : Varsha Dutta Publisher : Narosa Publishing House Pvt. Ltd. ISBN : 978-81-8487-570-6 Price : 1000rs/- Year of Publication : 2016 Pages : 108 pp Among the diseases that afflict the mind, depression is one of the most forbidding, a scourge that ranks very much on a par with Alzheimer's disease or with fulminant schizophrenia for its calamitous effects. It can at times descend on its...

Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.

European Neuropsychopharmacology May 20, 2016 Anna Rickli, Olivier D. Moning, Marius C. Hoener et al. 374 citations

The present study investigated interactions between the novel psychoactive tryptamines DiPT, 4-OH-DiPT, 4-OH-MET, 5-MeO-AMT, and 5-MeO-MiPT at monoamine receptors and transporters compared with the classic hallucinogens lysergic acid diethylamide (LSD), psilocin, N,N-dimethyltryptamine (DMT), and mescaline. We investigated binding affinities at human monoamine receptors and determined...

2-(4-IODO-2,5-DIMETOXIFENIL)-N-[(2-METOXIFENIL)METIL]ETAMINA OU 25I-NBOME: CARACTERIZAÇÃO QUÍMICA DE UMA DESIGNER DRUG

Química Nova May 9, 2016 Pâmella F. Dos Santos, Lindamara M. Souza, Bianca B. Merlo et al. 13 citations

Drug trafficking and the introduction of new drugs onto the illicit market are one of the main challenges of the forensic community. In this study, the chemical profile of a new designer drug, 2-(4-iodine-2,5-dimethoxyphenyl)-n-[(2-methoxyphenyl)methyl]etamine or 25I-NBOMe was explored using thin layer chromatography (TLC), ultraviolet-visible spectrophotometry (UV-Vis), attenuated total...

Psychedelic Drug Treatments

March 8, 2016 Ben Sessa, Eileen Worthley 1 citation

Psychedelic Drug Treatments: Assisting the Therapeutic Process provides information about current and quite viable investigation into reviving and progressing with neurological research that began in the middle of the 20th century and was brought to a halt when certain drugs were banned in the 1970s. Using a question/answer format, the book will introduce you to the way in which the chemical...

The Psychedelic Renaissance: Horizons, the Fifth Annual Conference on Psychedelic Research

Einstein Journal of Biology and Medicine March 2, 2016 Michael Cooper

In the spring of 1943, a 37-year-old Swiss chemist named Albert Hofmann had “a peculiar presentiment.” He believed that he had missed something in 1938, the year when he first synthesized the twenty-fifth compound of the lysergic acid diethylamide series, LSD-25. For eight years at Sandoz Pharmaceuticals, Hofmann was in charge of the ergot project, which involved synthesizing ergotamine...

Trajectories of drug use among French young people: Prototypical stages of involvement in illicit drug use

Journal of Substance Use January 20, 2016 Stéphanie Baggio, Stanislas Spilka, Joseph Studer et al. 9 citations

Aims: This study investigated patterns and trajectories of substance use, with a special focus on illicit drugs other than cannabis. It examined both patterns and trajectories of use among a general population-based sample. Methods: We used data from the 2011 French ESCAPAD survey of French 17-year-olds to assess exposure and age of initiation of 14 licit and illicit drugs (N=23,882). Latent...

An intravenous self-administration procedure for assessing the reinforcing effects of hallucinogens in nonhuman primates.

Journal of pharmacological and toxicological methods 2016 Amy K Goodwin

Self-administration procedures are the gold standard for investigating the reinforcing effects of drugs. The notable exception to good correspondence between laboratory self-administration studies and human drug taking behavior has historically been the classic hallucinogens. The present study used a well-established daily access procedure, followed by a novel intermittent access procedure, to...

DOI: 10.1016/j.vascn.2016.07.004 (opens in new tab) Full text (opens in new tab) Abuse liability Hallucinogen Intravenous iv self-administration Operant behavior +1

Case series: toxicity from 25B-NBOMe--a cluster of N-bomb cases.

Clinical Toxicology 2016 Paul Gee, Leo J. Schep, Berit P Jensen et al.

Background A new class of hallucinogens called NBOMes has emerged. This class includes analogues 25I-NBOMe, 25C-NBOMe and 25B-NBOMe. Case reports and judicial seizures indicate that 25I-NBOMe and 25C-NBOMe are more prevalently abused. There have been a few confirmed reports of 25B-NBOMe use or toxicity. Report Observational case series. This report describes a series of 10 patients who suffered...

DOI: 10.3109/15563650.2015.1115056 (opens in new tab) Full text (opens in new tab) 25b-nbome N-bomb Novel psychoactive substances Substituted phenylethylamines